NATIONAL INSTITUTES OF HEALTH SEARCH THIS SITE
NIMH LOGO AND LINK NIMH BANNER PHOTO 1NIMH BANNER PHOTO 2NIMH BANNER PHOTO 3NIMH BANNER PHOTO 4NIMH BANNER PHOTO 5NIMH BANNER PHOTO 6
Transforming the understanding and treatment of mental illness through research
DIVISION OF INTRAMURAL RESEARCH PROGRAMS
Link to DIRP Home Link to About DIRP Link to DIRP Research Link to DIRP Core Facilities Link to DIRP Information for Staff
 Principal Investigators

Charles Gerfen, Ph.D.
Charles Gerfen Photo   Dr. Gerfen received a B.A. from Amherst College and Ph.D. from Northwestern University. His doctoral research was on neural substrates of reward involving the prefrontal cortex and basal ganglia. During a post-doctoral fellowship in the Laboratory of Max Cowan at the Salk Institute, he developed the PHA-L axonal tracing technique with Paul Sawchenko. In 1983, Dr. Gerfen was recruited by Ed Evarts to the Laboratory of Neurophysiology at NIMH to work on the neuroanatomy of the forebrain, where he established some of the functional prinicples of the organization of the basal ganglia. Dr. Gerfen is currently the Chief of the Laboratory of Systems Neuroscience at the NIMH.
Research Interests

Dr. Gerfen's research goals involve elucidating the functional organization of the basal ganglia. Specifically, the lab studies receptor mediated gene regulation, with an emphasis on how functionally defined neurons in the forebrain display distinct forms of neuronal plasticity. While the role of the basal ganglia in behavior remains elusive, diseases that affect its function result in profound neurological disorders, including movement disorders such as Parkinson's disease, chorea, and dystonia, and mental disorders such as attention deficit hyperactivity disorder and depression. His research initially mapped out the connectional organization of this system, characterizing the compartmental nature of the input-output organization of the striatum, which is the main nucleus of the basal ganglia. This work identified the principal neuron types in the basal ganglia in terms of their neuroanatomical connections and neurochemical phenotype. Work is now focused on how the two main output neurons of the striatum, direct and indirect projection neurons, differ functionally through their distinct responses to glutamatergic excitatory inputs as modulated by their expression of D1 and D2 dopamine receptor subtypes. Current work examines differences in receptor-mediated signal transduction regulation of the gene expression underlying distinct forms of neuronal plasticity in direct and indirect striatal projection neurons. Particular emphasis is placed on determining the molecular basis of an aberrant form of neuronal plasticity that occurs in direct projection neurons in animal models of Parkinson's disease. Dr. Gerfen is a Co-Investigator on the Gene Expression Nervous System Atlas (GENSAT) project, with Nat Heintz at Rockefeller University. This project provides transgenic mouse lines to the neuroscience research community with neuron specific expression of Cre recombinase. Over 50 Cre-driver lines have been characterized with expression limited to specific neuron types or specific brain regions. Information and availability of these mice may be accessed through the GENSAT website.

 

Representative Selected Recent Publications:
  • Nadjar A, Gerfen CR, Bezard E. Priming for L-dopa-induced dyskinesia in Parkinson's disease: A feature inherent to the treatment of the disease? Prog Neurobiol. 87:1-9. 2009. <view>
  • Gerfen CR, Paletzki R, Worley PW. Differences between dorsal and ventral striatum in Drd1a-dopamine receptor coupling of DARPP-32 to activation of extracellular receptor kinase (ERK1/2). Journal of Neuroscience. 28:7113-7120. 2008. <view>
  • Gong S, Doughty M, Harbaugh CR, Cummins A, Hatten ME, Heintz N, Gerfen CR. Targeting CRE recombinase to specific neuron populations with Bacterial Artificial Chromosome constructs. Journal of Neuroscience. 27:9817-9823. 2007.
  • Brown P and Gerfen CR. Plasticity within striatal direct pathway neurons following neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK1/2/MAP Kinase pathway. J Comp Neurol. 498:415-430. 2006. <view>
  • Gerfen CR, Miyachi S, Paletzki R, Brown P: D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. Journal of Neuroscience, 22: 5042-5054, 2002. (View PDF)

Address:
Bldg 110/ Room 109
16701 Elmer School Road
Dickerson, MD 20842
Phone: 240-595-3390
Email Dr. Gerfen  
Fax:  
Lab Web Site: http://www.gensat.org/index.html
   
Research at DIRP Section
Principal Investigators
Scientists & Clinicians
DIRP Labs and Branches
DIRP Research Areas

About the DIRP Section
Office of the Scientific Director
Site Map
Participate in Research
Contact Us
Careers in Research
What’s New

Core Facilities Section
Functional MRI Core
Magnetic Resonance Core
Magnetoencephalography Core
Microarray Core
Neurophysiology Imaging Facility
Neurophysiology Imaging Facility
Scientific and Statistical Computing Core
Section on Instrumentation Core
Transgenic Core
Veterinary Medicine Resources (Staff only)

Information for Staff Section
Office of the Scientific Director
Office of the Clinical Director
Office of Fellowship Training
Office of Technology Transfer
Administrative Services Branch
Administrative Services




This page was last updated September 14, 2012.


  The Division of Intramural Research Programs is within the National Institute of Mental Health (NIMH) which is a part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services.
  NIH...Turning Discovery into Health LOGO DHHS LOGO USA GOV LOGO